Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2025Indian Journal of PharmacologyOpen Access

A case series of vildagliptin-associated bullous pemphigoid - Rare side effect

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMohit Kumar ShahiJAJ V AshwinASAstha Singh

Discussion

Loading...

Member takes

Overview

Case series reveals development of bullous pemphigoid in diabetes patients after vildagliptin use, suggesting caution.

Key Points

  • Three patients developed bullous pemphigoid after starting vildagliptin, indicating a potential risk.
  • The cases highlight the link between vildagliptin and skin eruptions, showing the importance of patient monitoring.
  • This observational case series focuses on the side effect of bullous pemphigoid from an emerging diabetes treatment.
  • Awareness of vildagliptin's possible connection to bullous pemphigoid is crucial for patient safety in diabetes management.

Cite This Study

Shahi et al. (2025) studied this question.

synapsesocial.com/papers/68af706e7567bf4f94febe95https://doi.org/10.4103/ijp.ijp_522_24
View Full Paper
Ask AI
Bookmark
Share